Cancer BiologybioRxiv
Loss of FBXO9 enhances proteasome activity and promotes aggressiveness in acute myeloid leukemia
R. W. Hynes-Smith, S. A. Swenson, H. Vahle…·S. M. Buckley
This study shows loss of FBXO9 increases proteasome activity and promotes aggressiveness in AML, suggesting potential for bortezomib treatment response prediction.
DOI 10.3390/cancers11111717